Full Text
The Full Text of this article is available as a PDF (97.1 KB).
. 2005 May 1;5(3):219–222. doi: 10.7861/clinmedicine.5-3-219
Anti-tumour necrosis factor therapy in seronegative spondyloarthritis
Catherine Swales
1, Paul Bowness
1
Catherine Swales, MRCP PhD
1Nuffield Orthopaedic Centre NHS Trust, Headington, Oxford
Clinical Lecturer in Rheumatology
Find articles by Catherine Swales
Paul Bowness, FRCP DPhil
1Nuffield Orthopaedic Centre NHS Trust, Headington, Oxford
Consultant Rheumatologist
Find articles by Paul Bowness
1Nuffield Orthopaedic Centre NHS Trust, Headington, Oxford
Roles
Catherine Swales: MRCP PhD, Clinical Lecturer in Rheumatology
Paul Bowness: FRCP DPhil, Consultant Rheumatologist
Key Words: ankylosing spondylitis, therapy, TNF
© 2005 Royal College of Physicians
PMCID: PMC4952201 PMID: 16011211